Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI
- PMID: 28593433
- DOI: 10.1007/s00330-017-4898-5
Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI
Abstract
Objectives: To investigate whether diffusion-weighted imaging (DWI) aids pre-operative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to evaluate additional lesions in breast cancer patients.
Methods: DCE-MRI and DWI were performed on 131 lesions, with available histopathological results. The apparent diffusion coefficient (ADC) of each lesion was measured, and the cut-off value for differentiation between malignant and benign lesions was calculated. A protocol combining the ADC cut-off value with DCE-MRI was validated in a cohort of 107 lesions in 77 patients.
Results: When an ADC cut-off value of 1.11 × 10-3 mm2/s from the development cohort was applied to the additional lesions in the validation cohort, the specificity increased from 18.9% to 67.6% (P < 0.001), and the diagnostic accuracy increased from 61.7% to 82.2% (P = 0.05), without significant loss of sensitivity (98.6% vs. 90.0%, P = 0.07). The negative predictive values of lesions in the same quadrant had decreased, as had those of lesions ≥1 cm in diameter. The ADC cut-off value in the validation cohort was 1.05 × 10-3 mm2/s.
Conclusions: Additional implementation of DWI for breast lesions in pre-operative MRI can help to obviate unnecessary biopsies by increasing specificity. However, to avoid missing cancers, clinicians should closely monitor lesions located in the same quadrant or lesions ≥1 cm.
Key points: • DWI can be used to further differentiate lesions during pre-operative cancer staging. • ADC cut-off values were similar in the development and validation cohorts. • DWI improves both PPV and NPV in cases of multicentric lesions. • DWI improves both PPV and NPV in lesions <1 in diameter. • NPVs are decreased in multifocal lesions and lesions ≥1 cm in diameter.
Keywords: Apparent diffusion coefficient; Breast magnetic resonance imaging; Breast neoplasm; Diffusion-weighted imaging; Staging.
Similar articles
-
Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.Acad Radiol. 2018 May;25(5):643-652. doi: 10.1016/j.acra.2017.11.011. Epub 2018 Jan 12. Acad Radiol. 2018. PMID: 29339079
-
Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging.Invest Radiol. 2018 Oct;53(10):587-595. doi: 10.1097/RLI.0000000000000465. Invest Radiol. 2018. PMID: 29620604 Free PMC article.
-
The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.Can Assoc Radiol J. 2021 Aug;72(3):460-469. doi: 10.1177/0846537120907098. Epub 2020 Mar 11. Can Assoc Radiol J. 2021. PMID: 32157892
-
Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.Eur Radiol. 2020 Mar;30(3):1436-1450. doi: 10.1007/s00330-019-06510-3. Epub 2019 Nov 30. Eur Radiol. 2020. PMID: 31786616 Free PMC article.
-
MR imaging in discriminating between benign and malignant paediatric ovarian masses: a systematic review.Eur Radiol. 2020 Feb;30(2):1166-1181. doi: 10.1007/s00330-019-06420-4. Epub 2019 Sep 16. Eur Radiol. 2020. PMID: 31529256 Free PMC article.
Cited by
-
Radiomics-based machine learning analysis and characterization of breast lesions with multiparametric diffusion-weighted MR.J Transl Med. 2021 Oct 24;19(1):443. doi: 10.1186/s12967-021-03117-5. J Transl Med. 2021. PMID: 34689804 Free PMC article.
-
BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management.Eur Radiol. 2020 May;30(5):2773-2781. doi: 10.1007/s00330-019-06620-y. Epub 2020 Jan 31. Eur Radiol. 2020. PMID: 32006168
-
Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients.Contrast Media Mol Imaging. 2022 Apr 6;2022:4224701. doi: 10.1155/2022/4224701. eCollection 2022. Contrast Media Mol Imaging. 2022. PMID: 35585943 Free PMC article.
-
Diffusion-Weighted Imaging in Oncology: An Update.Cancers (Basel). 2020 Jun 8;12(6):1493. doi: 10.3390/cancers12061493. Cancers (Basel). 2020. PMID: 32521645 Free PMC article. Review.
-
Optimising preoperative risk stratification tools for prostate cancer using mpMRI.Eur Radiol. 2018 Mar;28(3):1016-1026. doi: 10.1007/s00330-017-5031-5. Epub 2017 Oct 6. Eur Radiol. 2018. PMID: 28986636 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical